fda warning compounding semaglutide october 2025 GLP-1 Medications – Guidance and Compounded Products Congress Introduces SAFE Drugs Act

For patients, waiting means confidence that the drug is safe for years of use

The Outsourcing Facilities Association sued the FDA on Monday over its decision to declare Novo Nordisk's Wegovy and Ozempic are no longer in shortage

Observe patients carefully for signs and symptoms of acute pancreatitis, which may include persistent or severe abdominal pain (sometimes radiating to the back), with or without nausea or vomiting

However, in vitro, evidence suggests that hyperglycemia, a primary metabolic feature of T2DM, can lead to impaired GLP-1 secretion and L-cell differentiation

[10] This distinction matters in both directions

So far so good